SoftMining
The AI engine Fit Assessment
BetaSoftMining effectively leverages machine learning and pattern discovery to expand therapeutics, optimizing the drug discovery process with innovative AI technologies.
Blurb
SoftMining is an artificial intelligence-powered drug discovery company that provides materials for therapeutics.
HQ Location
Italy
Founded
2019
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Operating of a pharmaceutical platform for providing multiple services for computationally aided drug design and data mining. The company's application is used for toxicology and process optimization. AI-powered systems, drug performance, and new molecules and materials for therapeutics, enabling patients to improve the quality of life designing better and safer drugs, and exploiting biomedical data more efficiently.